Mangoceuticals Inc MGRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close
-
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders
-
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
-
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
-
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
Trading Information
- Previous Close Price
- $0.25
- Day Range
- $0.23–0.26
- 52-Week Range
- $0.16–2.41
- Bid/Ask
- $0.23 / $0.24
- Shares Outstanding
- 22.22M
- Market Cap
- $5.19M
- Volume/Avg
- 531,821 / 12M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.98
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 0
- Website
- https://www.mangoceuticals.com
Valuation
|
Metric
|
MGRX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.34 |
Price/Sales | 10.98 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MGRX
|
|---|---|
Quick Ratio | 0.16 |
Current Ratio | 0.18 |
Interest Coverage | −22.16 |
Quick Ratio
MGRX
Profitability
|
Metric
|
MGRX
|
|---|---|
Return on Assets (Normalized) | −32.59% |
Return on Equity (Normalized) | −35.89% |
Return on Invested Capital (Normalized) | −30.18% |
Return on Assets
MGRX
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|jTXW@%w | LOCK|Mgs | $51B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|#>?% | $14B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|V#?yY | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|Vxfb | $13B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|W<% | $13B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|Kh?@ | $9B | |||
| HealthEquity Inc
HQY
| — | LOCK|?Q#^& | $8B | |||
| M3 Inc
MTHRF
| — | LOCK|jF#R | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|f%%<r | $8B | |||
| Doximity Inc Class A
DOCS
| — | LOCK|#BX | $6B |
United States